Status:
COMPLETED
A Clinical Study to Assess the Effects of JoyRise Recovery Powder on Mitigating Alcohol Aftereffects.
Lead Sponsor:
Joyrise
Collaborating Sponsors:
Citruslabs
Conditions:
Alcohol Aftereffects
Anxiety
Eligibility:
All Genders
35-54 years
Phase:
NA
Brief Summary
This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants...
Eligibility Criteria
Inclusion
- Aged 35-54, male or female
- Regular alcohol consumption
- Event planned within one month that involves alcohol consumption
- Willingness to avoid new medications or supplements during the study period
- Must confirm that they will not drive while under the influence of alcohol.
Exclusion
- Anyone not in good health.
- Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
- Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
- Anyone who is pregnant, breastfeeding, or trying to conceive.
- Anyone who cannot/ will not commit to the study protocol.
- Anyone with a history of substance abuse.
- Anyone who has undergone an invasive medical procedure in the six months prior to the study, or has a procedure planned during the study duration.
- Anyone currently using any medications that may affect their response to alcohol or impact hangover symptoms, such as diuretics (water pills) or medication for hypertension.
- History of severe reactions or sensitivity to alcohol.
- Anyone currently taking glutathione.
Key Trial Info
Start Date :
June 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06575972
Start Date
June 25 2024
End Date
August 1 2024
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404